| 1 |
Ebru Koçak Aslan, Muhammed İhsan Han, Vagolu Siva Krishna, Rasoul Tamhaev, Cagatay Dengiz, Şengül Dilem Doğan, Christian Lherbet, Lionel Mourey, Tone Tønjum, Miyase Gözde Gündüz. Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity. Pharmaceuticals (Basel) 2022;15:1301. [PMID: 36297413 DOI: 10.3390/ph15101301] [Reference Citation Analysis]
|
| 2 |
Singh M, Kumar S, Singh B, Jain P, Kumari A, Pahuja I, Chaturvedi S, Prasad DVR, Dwivedi VP, Das G. The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway. Commun Biol 2022;5:759. [PMID: 35902694 DOI: 10.1038/s42003-022-03693-2] [Reference Citation Analysis]
|
| 3 |
Prigot-Maurice C, Depeux C, Paulhac H, Braquart-Varnier C, Beltran-Bech S. Immune priming in Armadillidiumvulgare against Salmonellaenterica: direct or indirect costs on life history traits? Zookeys 2022;1101:131-58. [PMID: 36760973 DOI: 10.3897/zookeys.1101.77216] [Reference Citation Analysis]
|
| 4 |
Souza IMS, Borrego-Sánchez A, Sainz-Díaz CI, Viseras C, Pergher SBC. Study of Faujasite zeolite as a modified delivery carrier for isoniazid. Mater Sci Eng C Mater Biol Appl 2021;118:111365. [PMID: 33254984 DOI: 10.1016/j.msec.2020.111365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 5 |
Huang CC, Becerra MC, Calderon R, Contreras C, Galea J, Grandjean L, Lecca L, Yataco R, Zhang Z, Murray M. Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis. Am J Respir Crit Care Med 2020;202:1159-68. [PMID: 32551948 DOI: 10.1164/rccm.201908-1576OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 6 |
Ma C, Wu M, Ye W, Huang Z, Ma X, Wang W, Wang W, Huang Y, Pan X, Wu C. Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties. Drug Deliv Transl Res 2021;11:1218-35. [PMID: 32946043 DOI: 10.1007/s13346-020-00849-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 7 |
Kassuya RM, Radai JAS, Macorini LFB, Nunes VK, Salvador MJ, Leite PRT, Oliveira RJ, Croda J, Arena AC, Kassuya CAL. Blutaparon portulacoides ethanolic extract reduced IL-1β and inflammatory parameters induced by the Mycobacterium complex and carrageenan in mice. Inflammopharmacology 2021;29:439-50. [PMID: 32910315 DOI: 10.1007/s10787-020-00752-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Khan SR, Manialawy Y, Siraki AG. Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action. Br J Pharmacol 2019;176:4599-608. [PMID: 31517993 DOI: 10.1111/bph.14867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
